Article
Certain Patients with Prostate Cancer Continue to Tolerate Extended Nubeqa Treatment
Rating:
0.0
Views:
105
Likes:
1
Library:
1
Patients with nonmetastatic castration-resistant prostate cancer continued to tolerate long-term treatment with Nubeqa, allowing them to maintain their quality of life and remain on therapy.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value